<PAGE> 1
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Introgen Therapeutics, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 74-2704230
--------------------------------------------------------------------------------
(State of incorporation or organization) (IRS Employer Identification No.)
301 Congress Avenue, Suite 1850, Austin, Texas 78701
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
NONE
--------------------------------------------------------------------------------
If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to
General Instruction A.(c), check the following box.
If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to
General Instruction A.(d), check the following box.
Securities Act registration statement file number to which this form
relates (if applicable): 333-30582
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $0.001 par value
--------------------------------------------------------------------------------
(Title of class)
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered
Incorporated by reference to "Description of Capital Stock"
set forth in the Registrant's Registration Statement on Form
S-1 originally filed with the Securities and Exchange
Commission on February 17, 2000 (File No. 333-30582) and all
amendments thereto (the "Form S-1")
Item 2. Exhibits
The following exhibits are filed as a part of this
registration statement:
1.* Specimen Common Stock certificate;
2.** Certificate of Incorporation, as amended and as currently in
effect;
3.*** Form of Certificate of Incorporation (to be filed upon
completion of the offering for which the Company is seeking
registration on the Form S-1);
----------
* Incorporated by reference to Exhibit 4.1 to the Form S-1.
** Incorporated by reference to Exhibit 3.1(a) to the Form S-1.
*** Incorporated by reference to Exhibit 3.1(b) to the Form S-1.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date: September 8, 2000
INTROGEN THERAPEUTICS, INC.
By: /s/ DAVID G. NANCE
---------------------------------
David G. Nance, President and CEO
